Abstract:Background: Despite the introduction of targeted therapies, most patients with myeloid malignancies will not be cured and progress. Genomics is useful to elucidate the mutational landscape but remains limited in the prediction of therapeutic outcome and identification of targets for resistance. Dysregulation of phosphorylation-based signaling pathways is a hallmark of cancer, and therefore, kinase-inhibitors are playing an increasingly important role as targeted treatments. Untargeted phosphoproteomics analysis pipelines have been published but show limitations in inferring kinase-activities and identifying potential biomarkers of response and resistance. Methods: We developed a phosphoproteomics workflow based on titanium dioxide phosphopeptide enrichment with subsequent analysis by liquid chromatography tandem mass spectrometry (LC-MS). We applied a novel Kinase-Activity Enrichment Analysis (KAEA) pipeline on differential phosphoproteomics profiles, which is based on the recently published SetRank enrichment algorithm with reduced false positive rates. Kinase activities were inferred by this algorithm using an extensive reference database comprising five experimentally validated kinase-substrate meta-databases complemented with the NetworKIN in-silico prediction tool. For the proof of concept, we used human myeloid cell lines (K562, NB4, THP1, OCI-AML3, MOLM13 and MV4-11) with known oncogenic drivers and exposed them to clinically established kinase-inhibitors. Results: Biologically meaningful over- and under-active kinases were identified by KAEA in the unperturbed human myeloid cell lines (K562, NB4, THP1, OCI-AML3 and MOLM13). To increase the inhibition signal of the driving oncogenic kinases, we exposed the K562 (BCR-ABL1) and MOLM13/MV4-11 (FLT3-ITD) cell lines to either Nilotinib or Midostaurin kinase inhibitors, respectively. We observed correct detection of expected direct (ABL, KIT, SRC) and indirect (MAPK) targets of Nilotinib in K562 as well as indirect (PRKC, MAPK, AKT, RPS6K) targets of Midostaurin in MOLM13/MV4-11, respectively. Moreover, our pipeline was able to characterize unexplored kinase-activities within the corresponding signaling networks. Conclusions: We developed and validated a novel KAEA pipeline for the analysis of differential phosphoproteomics MS profiling data. We provide translational researchers with an improved instrument to characterize the biological behavior of kinases in response or resistance to targeted treatment. Further investigations are warranted to determine the utility of KAEA to characterize mechanisms of disease progression and treatment failure using primary patient samples.

phuEGO: A network-based method to reconstruct active signalling pathways from phosphoproteomics datasets

Evaluating signaling pathway inference from kinase-substrate interactions and phosphoproteomics data

Phosphoproteomics data-driven signalling network inference: does it work?

Combining Phosphoproteomics Datasets and Literature Information to Reveal the Functional Connections in a Cell Phosphorylation Network

Phosphoproteomics‐based Network Medicine

Phosphomatics: interactive interrogation of substrate–kinase networks in global phosphoproteomics datasets

From Pathways to Networks: Connecting Dots by Establishing Protein-Protein Interaction Networks in Signaling Pathways Using Affinity Purification and Mass Spectrometry

Global, In Vivo, and Site-Specific Phosphorylation Dynamics in Signaling Networks

Using signaling domain information to reconstruct signal transduction pathway

Spatial-proteomics reveals phospho-signaling dynamics at subcellular resolution

Spatial-proteomics reveal in-vivo phospho-signaling dynamics at subcellular resolution

Data-driven extraction of human kinase-substrate relationships from omics datasets

GSGS: A Computational Approach to Reconstruct Signaling Pathway Structures from Gene Sets

Quantitative phosphoproteomics-based molecular network description for high-resolution kinase-substrate interactome analysis

Towards Systematic Discovery of Signaling Networks in Budding Yeast Filamentous Growth Stress Response Using Interventional Phosphorylation Data

Targeted proteomics analyses of phosphorylation-dependent signalling networks

Personalized phosphoproteomics identifies functional signaling

Inference of kinase-signaling networks in human myeloid cell line models by Phosphoproteomics using kinase activity enrichment analysis (KAEA)

Computational Approaches for Identifying Signaling Pathways from Molecular Interaction Networks

Inferring the Sign of Kinase-Substrate Interactions by Combining Quantitative Phosphoproteomics with a Literature-Based Mammalian Kinome Network

Phosphoproteomic and its application in cellular signaling network analysis